MediPharm Labs Announces Strong Q1 2025 Results
— Achieves Positive Adjusted EBITDA(1) — Revenue of $10.8 Million, an Increase of 11% over Q1 2024 — 87% Growth in International Medical Cannabis Revenue, Forming 55% of Total Revenue — Gross Profit of $4.2 million, or 39% of Total Revenue, Improved Significantly over Q1 2024 — Management to Host Conference Call / Webcast on […]